The Direct Medical Costs of α1-Antitrypsin Deficiency

This publication has 11 references indexed in Scilit:

• Should Health-Care Systems Pay for Replacement Therapy in Patients With α1-Antitrypsin Deficiency?
  Chest, 2000
• A national program for detection of α1-antitrypsin deficiency in Italy
  Respiratory Medicine, 1999
• Clinical Features and Natural History of Severe α1-Antitrypsin Deficiency
  Chest, 1997
• Baseline Characteristics of Enrollees in the National Heart, Lung and Blood Institute Registry of α1-Antitrypsin Deficiency
  Chest, 1997
• Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease.
  American Journal of Public Health, 1991
• Alpha-1-Antitrypsin Deficiency: High Prevalence in the St. Louis Area Determined by Direct Population Screening
  American Review of Respiratory Disease, 1989
• The Cost and Efficacy of Home Care for Patients With Chronic Lung Disease
  Medical Care, 1988
• Cost and Outcome of Care for Patients With Chronic Obstructive Lung Disease
  Medical Care, 1986
• Neonatal screening for alpha1-antitrypsin deficiency
  The Journal of Pediatrics, 1978
• Liver Disease in Alpha₁-Antitrypsin Deficiency Detected by Screening of 200,000 Infants
  New England Journal of Medicine, 1976